Mouse models of von Willebrand disease
- PMID: 19630770
- DOI: 10.1111/j.1538-7836.2009.03411.x
Mouse models of von Willebrand disease
Abstract
von Willebrand disease (VWD), caused by quantitative or qualitative abnormalities in von Willebrand factor (VWF) is considered the most common inherited bleeding disorder in humans. Mild and severe quantitative defects in VWF cause VWD types 1 and 3 respectively, whereas qualitative abnormalities induce VWD type 2. VWD has also been diagnosed in a number of animal species such as dogs, pigs, cats and horses, as a result of naturally occurring mutations. More recently, murine models have drawn a great deal of attention. Their small size along with their well-defined genetic background makes them ideal tools to study the in vivo function of VWF. The most commonly used model is the VWF-deficient mouse engineered through homologous recombination. However, models resulting from changes in modifier genes indirectly affecting VWF have also been described. These various models have proven very useful in elucidating some aspects of VWF biology not easily addressed through in vitro approaches.
Similar articles
-
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
-
Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.J Cardiothorac Vasc Anesth. 2022 Mar;36(3):724-727. doi: 10.1053/j.jvca.2021.01.038. Epub 2021 Jan 27. J Cardiothorac Vasc Anesth. 2022. PMID: 33618961
-
Laboratory diagnosis and molecular classification of von Willebrand disease.Acta Haematol. 2009;121(2-3):71-84. doi: 10.1159/000214846. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506352 Review.
-
High and long-term von Willebrand factor expression after Sleeping Beauty transposon-mediated gene therapy in a mouse model of severe von Willebrand disease.J Thromb Haemost. 2018 Mar;16(3):592-604. doi: 10.1111/jth.13938. Epub 2018 Jan 31. J Thromb Haemost. 2018. PMID: 29288565
-
Clinical significance of slightly reduced von Willebrand factor activity.Pol Arch Intern Med. 2020 Mar 27;130(3):225-231. doi: 10.20452/pamw.15162. Epub 2020 Jan 28. Pol Arch Intern Med. 2020. PMID: 31990275 Review.
Cited by
-
Utility of a high VWF: FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice.Blood Coagul Fibrinolysis. 2015 Jul;26(5):515-21. doi: 10.1097/MBC.0000000000000269. Blood Coagul Fibrinolysis. 2015. PMID: 25767894 Free PMC article.
-
Von Willebrand Disease: From In Vivo to In Vitro Disease Models.Hemasphere. 2019 Sep 27;3(5):e297. doi: 10.1097/HS9.0000000000000297. eCollection 2019 Oct. Hemasphere. 2019. PMID: 31942548 Free PMC article. Review.
-
Vwf K1362A resulted in failure of protein synthesis in mice.Int J Hematol. 2018 Apr;107(4):428-435. doi: 10.1007/s12185-017-2394-y. Epub 2018 Feb 1. Int J Hematol. 2018. PMID: 29392565
-
Von Willebrand factor is reversibly decreased during torpor in 13-lined ground squirrels.J Comp Physiol B. 2016 Jan;186(1):131-9. doi: 10.1007/s00360-015-0941-5. J Comp Physiol B. 2016. PMID: 26481634 Free PMC article.
-
Von Willebrand Factor Abnormalities Studied in the Mouse Model: What We Learned about VWF Functions.Mediterr J Hematol Infect Dis. 2013 Jul 10;5(1):e2013047. doi: 10.4084/MJHID.2013.047. Print 2013. Mediterr J Hematol Infect Dis. 2013. PMID: 23936618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous